Drug Safety Information for NORTHERA (Droxidopa)

Safety-related Labeling Changes for NORTHERA (DROXIDOPA) Rx Drug: FDA Link

Required post-approval safety study:

A clinical trial of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of droxidopa therapy. The trial design consists of a 3-month, open-label droxidopa treatment period, followed by a 3-month, randomized, double-blind, placebocontrolled, withdrawal period. The primary endpoint will be time to treatment intervention. Due Date: 2021-08-31

Original FDA Drug Approval Date for NORTHERA: 2014-02-18

Adverse Drug Reactions for NORTHERA* (Droxidopa)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with NORTHERA
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Blood pressure increased127
2Dizziness123
3Drug ineffective106
4Headache84
5Nausea63
6Fatigue60
7Fall54
8Hypertension47
9Blood pressure decreased47
10Hypotension40
11Malaise39
12Blood pressure fluctuation38
13Loss of consciousness35
14Confusional state35
15Feeling abnormal34
16Asthenia33
17Death33
18Drug dose omission30
19Tremor26
20Syncope25

* This side effect also appears in "Top 10 Side Effects of NORTHERA " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking NORTHERA
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Orthostatic hypotension820
2Product used for unknown indication428
3Parkinson's disease309
4Dizziness176
5Autonomic neuropathy154
6Autonomic failure syndrome68
7Hypotension42
8Autonomic nervous system imbalance38
9Syncope35
10Multiple system atrophy32

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for NORTHERA

Total Reports Filed with FDA: 2537


Number of FDA Adverse Event Reports by Patient Age for NORTHERA

Total Reports Filed with FDA: 2537*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Droxidopa (Northera)

Charts are based on 2537 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and NORTHERA Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on NORTHERA's side effects.